Celestica, Inc (NYSE: CLS) established initial surge of 8.96% at $269.96, as the Stock market unbolted on Wednesday, before settling in for the price of $247.75 at the close. Taking a more long-term approach, CLS posted a 52-week range of $55.30-$270.15.
In the past 5-years timespan, the Technology sector firm’s annual sales growth was 46.52%. Meanwhile, its Annual Earning per share during the time was 46.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 43.43%. This publicly-traded company’s shares outstanding now amounts to $115.00 million, simultaneously with a float of $114.44 million. The organization now has a market capitalization sitting at $31.05 billion.
Celestica, Inc (CLS) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Celestica, Inc industry. Celestica, Inc’s current insider ownership accounts for 0.52%, in contrast to 74.26% institutional ownership. According to the most recent insider trade that took place on Jan 06 ’25, this organization’s Director sold 25,000 shares at the rate of 98.73, making the entire transaction reach 2,468,250 in total value, affecting insider ownership by 1,784.
Celestica, Inc (CLS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.5 per share during the current fiscal year.
Celestica, Inc’s EPS increase for this current 12-month fiscal period is 43.43% and is forecasted to reach 7.05 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 31.27% through the next 5 years, which can be compared against the 46.52% growth it accomplished over the previous five years trading on the market.
Celestica, Inc (NYSE: CLS) Trading Performance Indicators
Let’s observe the current performance indicators for Celestica, Inc (CLS). It’s Quick Ratio in the last reported quarter now stands at 0.86. Alongside those numbers, its PE Ratio stands at $58.64, and its Beta score is 1.84. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.93. Similarly, its price to free cash flow for trailing twelve months is now 80.71.
In the same vein, CLS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 4.60, a figure that is expected to reach 1.47 in the next quarter, and analysts are predicting that it will be 7.05 at the market close of one year from today.
